GW&K Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48K Buy
1,006
+40
+4% +$1.86K ﹤0.01% 571
2025
Q4
$47K Hold
966
﹤0.01% 568
2025
Q3
$46K Hold
966
﹤0.01% 543
2025
Q2
$47K Hold
966
﹤0.01% 525
2025
Q1
$54K Hold
966
﹤0.01% 480
2024
Q4
$47K Hold
966
﹤0.01% 485
2024
Q3
$56K Hold
966
﹤0.01% 453
2024
Q2
$47K Hold
966
﹤0.01% 451
2024
Q1
$47K Buy
966
+645
+201% +$31.5K ﹤0.01% 436
2023
Q4
$16K Hold
321
﹤0.01% 557
2023
Q3
$17K Buy
321
+110
+52% +$5.87K ﹤0.01% 508
2023
Q2
$11K Buy
+211
New +$11.4K ﹤0.01% 590

Other funds holding SNY

GW&K Investment Management's SNY Position: Q1 2026 in Review

GW&K Investment Management increased its Sanofi (SNY) stake by 4.1% in Q1 2026, buying an estimated $1.86K and bringing the position to 1,006 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

GW&K Investment Management first reported a position in SNY in Q2 2023 and has held it in 12 quarters since. The position peaked at $56K in Q3 2024. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • GW&K Investment Management held 1,006 shares of Sanofi worth $48K as of Q1 2026.
  • GW&K Investment Management bought 40 Sanofi shares in Q1 2026, an estimated $1.86K.
  • Sanofi made up ﹤0.01% of GW&K Investment Management's portfolio in Q1 2026, its #571 holding.
  • GW&K Investment Management first reported a position in Sanofi in Q2 2023 and has held it in 12 quarters since.
  • GW&K Investment Management's Sanofi position peaked at $56K in Q3 2024.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.